Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Vainchtein

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Trends in Neurosciences|February 12, 2020
Astrocytes and Microglia: In Sickness and in HealthIlia D Vainchtein, Anna V Molofsky
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|June 4, 2008
Tailored mixing inside a translating dropletR Chabreyrie, D Vainchtein, C Chandre, et al.
Biomedical Chromatography : BMC|August 4, 2009
A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasmaLiia D Vainchtein, Hilde Rosing, Jan H M Schellens, et al.
Rapid Communications in Mass Spectrometry : RCM|June 20, 2007
Validated assay for the simultaneous determination of the anti-cancer agent gemcitabine and its metabolite 2',2'-difluorodeoxyuridine in human plasma by high-performance liquid chromatography with tandem mass spectrometryLiia D Vainchtein, Hilde Rosing, Bas Thijssen, et al.
Nature Communications|October 9, 2021
In situ and transcriptomic identification of microglia in synapse-rich regions of the developing zebrafish brainNicholas J Silva, Leah C Dorman, Ilia D Vainchtein, et al.
Biomedical Chromatography : BMC|July 26, 2005
A simple and sensitive assay for the quantitative analysis of paclitaxel and metabolites in human plasma using liquid chromatography/tandem mass spectrometryLiia D Vainchtein, Bas Thijssen, Ellen Stokvis, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 22, 2006
Stability experiments in human urine with EO9 (apaziquone): a novel anticancer agent for the intravesical treatment of bladder cancerLiia D Vainchtein, Hilde Rosing, Dorla Mirejovsky, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 17, 2007
Quantitative and selective assay of 5-methylindirubine, an inhibitor of cyclin-dependent kinases, in murine plasma using coupled liquid chromatography and electrospray tandem mass spectrometryLiia D Vainchtein, Hilde Rosing, Armin Maier, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 8, 2017
Isolation of Microglia and Immune Infiltrates from Mouse and Primate Central Nervous SystemThais F Galatro, Ilia D Vainchtein, Nieske Brouwer, et al.
Rapid Communications in Mass Spectrometry : RCM|January 31, 2008
Enhanced resolution triple-quadrupole mass spectrometry for ultra-sensitive and quantitative analysis of the investigational anticancer agent EO9 (apaziquone) and its metabolite EO5a in human and dog plasma to support (pre)-clinical studies of EOquin given intravesicallyLiia D Vainchtein, Hilde Rosing, Dorla Mirejovsky, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Trends in Neurosciences|February 12, 2020
Astrocytes and Microglia: In Sickness and in HealthIlia D Vainchtein, Anna V Molofsky
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|June 4, 2008
Tailored mixing inside a translating dropletR Chabreyrie, D Vainchtein, C Chandre, et al.
Biomedical Chromatography : BMC|August 4, 2009
A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasmaLiia D Vainchtein, Hilde Rosing, Jan H M Schellens, et al.
Rapid Communications in Mass Spectrometry : RCM|June 20, 2007
Validated assay for the simultaneous determination of the anti-cancer agent gemcitabine and its metabolite 2',2'-difluorodeoxyuridine in human plasma by high-performance liquid chromatography with tandem mass spectrometryLiia D Vainchtein, Hilde Rosing, Bas Thijssen, et al.
Nature Communications|October 9, 2021
In situ and transcriptomic identification of microglia in synapse-rich regions of the developing zebrafish brainNicholas J Silva, Leah C Dorman, Ilia D Vainchtein, et al.
Biomedical Chromatography : BMC|July 26, 2005
A simple and sensitive assay for the quantitative analysis of paclitaxel and metabolites in human plasma using liquid chromatography/tandem mass spectrometryLiia D Vainchtein, Bas Thijssen, Ellen Stokvis, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 22, 2006
Stability experiments in human urine with EO9 (apaziquone): a novel anticancer agent for the intravesical treatment of bladder cancerLiia D Vainchtein, Hilde Rosing, Dorla Mirejovsky, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 17, 2007
Quantitative and selective assay of 5-methylindirubine, an inhibitor of cyclin-dependent kinases, in murine plasma using coupled liquid chromatography and electrospray tandem mass spectrometryLiia D Vainchtein, Hilde Rosing, Armin Maier, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 8, 2017
Isolation of Microglia and Immune Infiltrates from Mouse and Primate Central Nervous SystemThais F Galatro, Ilia D Vainchtein, Nieske Brouwer, et al.
Rapid Communications in Mass Spectrometry : RCM|January 31, 2008
Enhanced resolution triple-quadrupole mass spectrometry for ultra-sensitive and quantitative analysis of the investigational anticancer agent EO9 (apaziquone) and its metabolite EO5a in human and dog plasma to support (pre)-clinical studies of EOquin given intravesicallyLiia D Vainchtein, Hilde Rosing, Dorla Mirejovsky, et al.
Pageof 4